The SAAAVE Act and Routine Ambulatory Medical Care Fail to Diagnose Patients with Abdominal Aortic Aneurysms prior to Rupture: A Single-Institution Experience

Table 1

Demographics, medical comorbidities, and current medical therapy in 52 patients evaluated in the outpatient setting ≤6 months of diagnosis of ruptured AAA.

Variable	Mean ± SD	Total 52
		n (%)
Age (years)	73.5 ± 8.9
Male		36 (69)
Female		16 (31)
Hypertension		42 (80.8)
Peripheral vascular disease		13 (25)
Diabetes		15 (28.8)
Hyperlipidemia		32 (61.5)
Coronary artery disease		27 (51.9)
Chronic obstructive pulmonary disease		20 (38.5)
Congestive heart failure		5 (9.6)
Chronic kidney disease		19 (36.5)
Smoking
Never		4 (7.7)
Current		21 (40.4)
Quit		16 (30.8)
Unknown		11 (21.1)
Aspirin		30 (55.6)
Clopidogrel		5 (9.3)
Beta blocker		28 (51.9)
Statin		27 (50)
ACEI/ARB		24 (44.4)

AAA: abdominal aortic aneurysm; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; chronic kidney disease, GFR < 60.